Short answer · Medically reviewed summary · Last updated: 2026-04-06
Lyme disease is considered a common infectious condition in endemic regions, with the CDC estimating approximately 476,000 new cases diagnosed and treated in the United States annually, though the true prevalence remains difficult to quantify due to significant underreporting. Incidence and Prevalence Challenges While often categorized as an infectious disease rather than a "rare disease" by traditional definitions, Lyme disease presents unique diagnostic challenges that mirror those seen in the rare disease community. The incidence of Lyme disease is highly dependent on geographic location, specifically where the Ixodes tick vector is prevalent.
15 people with Lyme Disease have shared their first-person experience on this question at DiseaseMaps.
Lyme disease is considered a common infectious condition in endemic regions, with the CDC estimating approximately 476,000 new cases diagnosed and treated in the United States annually, though the true prevalence remains difficult to quantify due to significant underreporting.
While often categorized as an infectious disease rather than a "rare disease" by traditional definitions, Lyme disease presents unique diagnostic challenges that mirror those seen in the rare disease community. The incidence of Lyme disease is highly dependent on geographic location, specifically where the Ixodes tick vector is prevalent. Because many cases are missed or misdiagnosed due to non-specific symptoms, the actual number of people currently living with the long-term effects of Lyme disease is likely higher than official surveillance data suggests.
Lyme disease does not discriminate by gender, though some studies suggest higher incidence in males, which is often attributed to greater exposure during outdoor occupational or recreational activities. Regarding age, Lyme disease exhibits a bimodal distribution, with the highest incidence rates observed in children aged 5–9 and adults aged 45–59. Geographically, the condition is heavily concentrated in the Northeastern, Mid-Atlantic, and North-Central United States, as well as parts of Europe and Asia.
At DiseaseMaps.org, our community of over 4,200 individuals living with Lyme disease highlights a critical gap between clinical surveillance and the patient experience. Many members report years of diagnostic delays, suggesting that official prevalence statistics may underestimate the burden of chronic symptoms. This real-world data is vital for understanding the true impact of the condition beyond the acute infection phase.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.